Serum phospholipase A 2 activity in patients with rheumatoid arthritis before and after treatment with methotrexate, auranofin, or combination of the two

Journal of Rheumatology

Volumn 23, Issue 2, 1996, Pages 226-229

  Michaels, Robert M ^a   Reading, James C ^b   Beezhold, Donald H ^d   Ward, John R ^c  

^a GUTHRIE RESEARCH INSTITUTE   (United States)

^b Division of Epidemiology   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

Auranofin; Methotrexate; Rheumatoid arthritis; Serum phospholipase A 2

Indexed keywords

AURANOFIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPASE A2; PHOSPHOLIPASE A;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; BLOOD; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; JOINT; MIDDLE AGED; PAIN; PATHOPHYSIOLOGY;

ADULT; ARTHRITIS, RHEUMATOID; AURANOFIN; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; JOINTS; MALE; METHOTREXATE; MIDDLE AGED; PAIN; PHOSPHOLIPASES A;

EID: 0029662356     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. 2s and inflammation. Ann Rheum Dis 1989;48:67-70.
2. Kelley WN, Harris ED, Ruddy S, et al: Textbook of Rheumatology (4th ed); Philadelphia: WB Saunders, 1993:853-4.
3. 2 correlates with disease activity in rheumatoid arthritis. J Rheumatol 1988;15:1351-5.
4. Williams HJ, Ward JR, Reading JC, et al: Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis: A controlled clinical trial. Arthritis Rheum 1992;35:259-69.
5. Steinbrocker O, Traeger CH, Batterman PC: Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
6. 2 and its role in the pathogenesis of inflammation in rheumatoid arthritis (editorial), J Rheumatol 1988;15:1601-3.
7. Kramer RM, Pepinsky RB: Assay and purification of phospholipase A, from human synovial fluid in rheumatoid arthritis. Methods Enzymol 1991;197 373-81.
8. 2: A mediator between proximal and distal effectors of inflammation. Immunol Today 1991;11:143-6.
9. Bomalaski JS, Clark MA: Phospholipase A and arthritis. Arthritis Rheum 1993;36:190-8.
10. 2 in the pathology of disease. Lab Invest 1986;55:391-404.
11. 2. Am J Pathol 1989;134:807-11.
12. 2 indices on inflammatory response in rabbit joints. J Immunol 1991;146:3904-10.
13. 2 in inflammation. Adv Inflamm Res 1984,.7:52-9.
14. 2 and C activities of peripheral blood polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Leukoc Biol 1986;29:312-8
15. Bomalaski JS, Clark MA, Zurier RB: Enhanced phospholipase activity in peripheral blood monocytes from patients with rheumatoid arthritis. Arthritis Rheum 1986;29:312-8.
16. 2 activity in peripheral blood cells of rheumatoid arthritis patients treated with methotrexate. Clin Exp Rheumatol 1994;12:643-7.